Cargando…
Common Minor Histocompatibility Antigen Discovery Based upon Patient Clinical Outcomes and Genomic Data
BACKGROUND: Minor histocompatibility antigens (mHA) mediate much of the graft vs. leukemia (GvL) effect and graft vs. host disease (GvHD) in patients who undergo allogeneic stem cell transplantation (SCT) [1], [2], [3], [4]. Therapeutic decision making and treatments [5] based upon mHAs will require...
Autores principales: | Armistead, Paul M., Liang, Shoudan, Li, Hua, Lu, Sijie, Van Bergen, Cornelis A. M., Alatrash, Gheath, St. John, Lisa, Hunsucker, Sally A., Sarantopoulos, Stefanie, Falkenburg, J. H. Frederik, Molldrem, Jeffrey J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3153501/ https://www.ncbi.nlm.nih.gov/pubmed/21858034 http://dx.doi.org/10.1371/journal.pone.0023217 |
Ejemplares similares
-
Autosomal Minor Histocompatibility Antigens: How Genetic Variants Create Diversity in Immune Targets
por: Griffioen, Marieke, et al.
Publicado: (2016) -
Optimized Whole Genome Association Scanning for Discovery of HLA Class I-Restricted Minor Histocompatibility Antigens
por: Fuchs, Kyra J., et al.
Publicado: (2020) -
Targeting PR1 in myeloid leukemia
por: Alatrash, Gheath, et al.
Publicado: (2017) -
Shared graft-versus-leukemia minor histocompatibility antigens in DISCOVeRY-BMT
por: Olsen, Kelly S., et al.
Publicado: (2022) -
PR1-Specific T Cells Are Associated with Unmaintained Cytogenetic Remission of Chronic Myelogenous Leukemia After Interferon Withdrawal
por: Kanodia, Shreya, et al.
Publicado: (2010)